Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.
Pitot HC, Wender DB, O'Connell MJ, Schroeder G, Goldberg RM, Rubin J, Mailliard JA, Knost JA, Ghosh C, Kirschling RJ, Levitt R, Windschitl HE.
Pitot HC, et al. Among authors: ghosh c.
J Clin Oncol. 1997 Aug;15(8):2910-9. doi: 10.1200/JCO.1997.15.8.2910.
J Clin Oncol. 1997.
PMID: 9256135
Clinical Trial.